EPH29 The Cost of Managing Safety Events: Ozanimod Versus Tofacitinib – A UK Perspective
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.951
https://www.valueinhealthjournal.com/article/S1098-3015(22)03156-4/fulltext
Title :
EPH29 The Cost of Managing Safety Events: Ozanimod Versus Tofacitinib – A UK Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03156-4&doi=10.1016/j.jval.2022.09.951
First page :
Section Title :
Open access? :
No
Section Order :
10493